---
figid: PMC3919553__nihms-535289-f0009
figlink: /pmc/articles/PMC3919553/figure/F9/
number: F9
caption: Schematic diagram depicts the underlying mechanism by which LOV protects
  OLs from cytokine toxicity. 1, TNF-α and IL-17-induced signaling mechanisms induce
  ROS generation thereby affecting peroxisome (P) and mitochondria (M) functions via
  activation of NADPH oxidase in OLs (). 2, LOV-mediated inhibition of mevalonate
  synthesis depletes the intracellular level of isoprenoids including geranylgeranyl-pyrophosphate
  (GGPP) leading to the inhibition of small Rho family GTPases, i.e., RhoA, cdc42,
  and Rac1 thus Rho-associated kinase (ROCK) activity in OLs. 3, ROCK activity inhibition
  enhances cPLA2 phosphorylation that releases arachidonic acid from phospholipids
  (membrane), a substrate of COX-2 that produces PPARs ligands via activation of ERK
  (1/2) and p38 MAPK in OLs. P38 MAPK also induces PGC-1α transactivation that, in
  turn, enhances PPAR-α-dependent transcription of catalase and SOD2 genes in OLs.
pmcid: PMC3919553
papertitle: Modulation of Rho-ROCK Signaling Pathway Protects Oligodendrocytes Against
  Cytokine Toxicity via PPAR-α-Dependent Mechanism.
reftext: Ajaib S. Paintlia, et al. Glia. ;61(9):1500-1517.
pmc_ranked_result_index: '65195'
pathway_score: 0.935096
filename: nihms-535289-f0009.jpg
figtitle: Schematic diagram depicts the underlying mechanism by which LOV protects
  OLs from cytokine toxicity
year: ''
organisms:
- Homo sapiens
ndex: 76bf9201-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3919553__nihms-535289-f0009.html
  '@type': Dataset
  description: Schematic diagram depicts the underlying mechanism by which LOV protects
    OLs from cytokine toxicity. 1, TNF-α and IL-17-induced signaling mechanisms induce
    ROS generation thereby affecting peroxisome (P) and mitochondria (M) functions
    via activation of NADPH oxidase in OLs (). 2, LOV-mediated inhibition of mevalonate
    synthesis depletes the intracellular level of isoprenoids including geranylgeranyl-pyrophosphate
    (GGPP) leading to the inhibition of small Rho family GTPases, i.e., RhoA, cdc42,
    and Rac1 thus Rho-associated kinase (ROCK) activity in OLs. 3, ROCK activity inhibition
    enhances cPLA2 phosphorylation that releases arachidonic acid from phospholipids
    (membrane), a substrate of COX-2 that produces PPARs ligands via activation of
    ERK (1/2) and p38 MAPK in OLs. P38 MAPK also induces PGC-1α transactivation that,
    in turn, enhances PPAR-α-dependent transcription of catalase and SOD2 genes in
    OLs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK12
  - MAPK9
  - MAPK14
  - MAPK11
  - MAPK3
  - MAPK1
  - PPARA
  - SOD2
  - MAPK8
  - TCF23
  - MAPK13
  - PPARGC1A
  - ROCK1
  - OPN1LW
  - RHOD
  - MAPK10
  - KAT5
  - ROCK2
  - Arachidonic Acid
  - Cholesterol
  - Lovastatin
  - Mevalonate
  - Squalene
genes:
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PPAR-a
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SOD2
  symbol: SOD2
  source: hgnc_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: OUT
  symbol: OUT
  source: hgnc_alias_symbol
  hgnc_symbol: TCF23
  entrez: '150921'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PGC-1a
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
chemicals:
- word: Arachidonic Acid
  source: MESH
  identifier: D001095
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Lovastatin
  source: MESH
  identifier: D008148
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Squalene
  source: MESH
  identifier: D013185
diseases: []
figid_alias: PMC3919553__F9
redirect_from: /figures/PMC3919553__F9
figtype: Figure
---
